Your Brain Has a Read Receipt Now

Doctors have always had to guess what's happening inside a living brain at the genetic level. A new tool from Rice University just made that guess unnecessary.

Bioengineers at Rice have developed a way to map gene activity in living brain tissue based solely on a blood sample. The method, published in Nature Communications, is called INTACT — short for In-vivo Tracking of Active Transcription — and it is the first demonstration of measuring transcription for targeted genes nondestructively in living tissue, according to lead researcher Jerzy Szablowski.

The backbone of the system is something called released markers of activity, or RMAs: engineered proteins designed to cross the blood-brain barrier and persist in the blood for hours, acting as messengers that carry gene-activity data out of a place that normally doesn't let anything out. Prior technologies required destroying the analyzed tissue, which meant they could only be used on excised samples or cells grown in a petri dish. Unlike those approaches, INTACT monitors gene expression in living tissue across multiple time points.

The targeting is also programmable. Researchers can monitor any gene by including its sequence in the genetic construct, without a bespoke reagent for each target. That means INTACT could, in theory, track genes associated with Parkinson's, Alzheimer's or a specific neural circuit and measure how those genes respond to medication, environmental factors or the progression of disease.

The brain still won't tell you everything. But now it's at least filing a report.

Read the full story at Phys.org, June 1, 2026

Hot Take: Every few years neuroscience quietly breaks something that was supposed to be unbreakable, and the blood-brain barrier was always the gold standard of "no, seriously, you can't get in there," so the fact that researchers engineered a molecule to just walk back out carrying notes is the kind of thing that should probably be a bigger deal than it is.